Friday July 18, 2014

ABK Biomedical Receives $2.14M in funding

Posted in: News

BOYNECLARKE LLP congratulates ABK Biomedical Inc. on being awarded $2.14 Million from the Atlantic Canada Opportunities Agency (ACOA), under the Atlantic Innovation Fund (AIF).

Founded by interventional radiologist, Dr. Bob Abraham and materials scientists Dr. Daniel Boyd and Dr. Sharon Kehoe, ABK Biomedical Inc. is a research and development company pursuing development, production and sale of embolic agents and peripheral vascular delivery devices.  ABK innovates integrated devices to simplify clinical procedures performed by interventional radiologists, with the lead system OccluRad /OccluDel, targeting hypervascular tumours including uterine fibroids.  The AIF funding will support the development and commercialization of biomaterials that will simplify and enhance the delivery of chemotherapy and radiotherapy for cancer patients.

Congratulations to ABK Biomedical on your recent success!

Share This Post:

Recent Blog Posts

News | Wednesday August 21, 2019

Twenty BOYNECLARKE LLP Lawyers Included in The Best Lawyers in Canada 2020

Posted in:

BOYNECLARKE LLP is pleased to announce that 20 of their lawyers have been included in The Best Lawyers in Canada 2020 publication by Best Lawyers®.

Read full article
News | Friday August 9, 2019

Summer School Lunch Seminar

Posted in:

Join us for lunch on August 14!

Read full article
News | Tuesday August 6, 2019

Brian P. Casey, Q.C. Named Fellow of the Litigation Counsel of America

Posted in:

BOYNECLARKE LLP is pleased to announce that Brian P. Casey, Q.C. has been selected as a fellow of the Litigation Counsel of America (LCA).

Read full article
News | Friday July 12, 2019

Congratulations Kathryn!

Posted in:

We congratulate our partner on her part-time appointment to the Canadian Human Rights Tribunal. 

Read full article